Exploring rifamycin cytotoxic potential through targeted liposomal formulations. - Ataide JA; Filipczak N; Yalamarty SSK; Rajmalani BA; Luther E; Mazzola PG; Torchilin VP (International journal of pharmaceutics, 2026)